Given the focus on developing Dietary Reference Intakes (DRIs) based on chronic disease risk reduction and recent research for omega-3 long chain PUFA since the last DRI review, the Canadian Nutrition Society convened a panel of stakeholders for a 1-day workshop in late 2019. Attendees discussed the new NASEM guidelines for establishing DRI values based on chronic disease risk endpoints and the strength of current evidence for EPA and DHA as it relates to the new guidelines. Novelty: Summarizes evidence and expert opinions regarding the potential for reviewing DRI values for EPA and DHA and cardiovascular disease risk and early development.
Keywords: acide docosahexaénoïque; acide eicosapentaénoïque; acides gras oméga-3; apports nutritionnels de référence; cardiovascular disease; chronic disease; dietary reference intakes; docosahexaenoic acid; eicosapentaenoic acid; health outcomes; maladie cardiovasculaire; maladie chronique; naissance prématurée; omega-3 fatty acids; pre-term birth; état de santé.